Cite
MLA Citation
Kathryn R. Wagner et al.. “Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial.” Muscle & nerve, vol. 64, no. 3, 2021, pp. 285–292. http://access.bl.uk/ark:/81055/vdc_100140211735.0x000046